Original Article

ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice

Correspondence to: Li-Shin Huang.

To study the role of low levels of high density lipoprotein (HDL) and apolipoprotein (apo) A-I in atherosclerosis risk, human apoB transgenic mice (HuBTg) were crossed with apoA-I-deficient (apoA-I^-/-) mice. After a high fat challenge, total cholesterol levels increased drastically due to an increase in the non-HDL cholesterol as confirmed by FPLC analysis. In addition, total cholesterol levels in A-I^-/- HuBTg mice were lower than the control HuBTg mice, due mainly to decreased HDL-C in A-I^-/- HuBTg mice. Analysis of atherosclerosis in the proximal aorta in mice fed a high-fat Western-type diet for 27 weeks revealed a 200% greater lesion area in female apoA-I^-/- HuBTg mice (49740 ± 9751 µm²) compared to control HuBTg mice (23320 ± 4981 µm², P = 0.03). Lesion size (12380 ± 3281 µm²) in male A-I^-/- HuBTg mice was also about 200% greater than that in the control HuBTg mice (5849 ± 1543 µm²), although not statistically significant. Very few and small lesions were observed in both apoA-I^-/- HuBTg and control HuBTg animals fed a chow diet. Therefore, the adverse effect of low HDL on atherosclerosis in mice was only evident when LDL-cholesterol was markedly elevated by high-fat challenge. Male apoA-I^-/- HuBTg mice exhibited hypertriglyceridemia when challenged with a high-fat diet. This correlated with both a reduction in lipoprotein lipase activity and a decrease in lipoprotein lipase activation by HDL.

In summary, low high density lipoprotein levels due to apolipoprotein A-I deficiency exacerbated the development of atherosclerotic lesions in mice with elevated atherogenic lipoproteins. This mouse model mimics human conditions associated with low HDL levels and provides additional evidence for the anti-atherogenic role of apoA-I.—Voyiaziakis, E., I. J. Goldberg, A. S. Plump, E. M. Rubin, J. L. Breslow, and L-S. Huang. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. J. Lipid Res. 1998. 39: 313–321.

Supplementary key words: apoA-I, apoB, atherosclerosis, hypertriglyceridemia, lipoproteins

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. Conde-Knape, K. Okada, R. Ramakrishnan, and N. S. Shachter Overexpression of apoC-III produces lesser hypertriglyceridemia in apoB-48-only gene-targeted mice than in apoB-100-only mice J. Lipid Res., December 1, 2004; 45(12): 2235 - 2244. [Abstract] [Full Text] [PDF]

				F. Boukhtouche, J. Mariani, and A. Tedgui The "CholesteROR" Protective Pathway in the Vascular System Arterioscler. Thromb. Vasc. Biol., April 1, 2004; 24(4): 637 - 643. [Abstract] [Full Text] [PDF]

				D. S. Ng, C. Xie, G. F. Maguire, X. Zhu, F. Ugwu, E. Lam, and P. W. Connelly Hypertriglyceridemia in Lecithin-cholesterol Acyltransferase-deficient Mice Is Associated with Hepatic Overproduction of Triglycerides, Increased Lipogenesis, and Improved Glucose Tolerance J. Biol. Chem., February 27, 2004; 279(9): 7636 - 7642. [Abstract] [Full Text] [PDF]

				A. Morishima, N. Ohkubo, N. Maeda, T. Miki, and N. Mitsuda NF{kappa}B Regulates Plasma Apolipoprotein A-I and High Density Lipoprotein Cholesterol through Inhibition of Peroxisome Proliferator-activated Receptor {alpha} J. Biol. Chem., October 3, 2003; 278(40): 38188 - 38193. [Abstract] [Full Text] [PDF]

				R. E. Moore, M.-a. Kawashiri, K. Kitajima, A. Secreto, J. S. Millar, D. Pratico, and D. J. Rader Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1914 - 1920. [Abstract] [Full Text] [PDF]

				M. Zabalawi, S. Bhat, T. Loughlin, M. J. Thomas, E. Alexander, M. Cline, B. Bullock, M. Willingham, and M. G. Sorci-Thomas Induction of Fatal Inflammation in LDL Receptor and ApoA-I Double-Knockout Mice Fed Dietary Fat and Cholesterol Am. J. Pathol., September 1, 2003; 163(3): 1201 - 1213. [Abstract] [Full Text] [PDF]

				R. J. Aiello, D. Brees, and O. L. Francone ABCA1-Deficient Mice: Insights Into the Role of Monocyte Lipid Efflux in HDL Formation and Inflammation Arterioscler. Thromb. Vasc. Biol., June 1, 2003; 23(6): 972 - 980. [Abstract] [Full Text] [PDF]

				R. van Haperen, A. van Tol, T. van Gent, L. Scheek, P. Visser, A. van der Kamp, F. Grosveld, and R. de Crom Increased Risk of Atherosclerosis by Elevated Plasma Levels of Phospholipid Transfer Protein J. Biol. Chem., December 6, 2002; 277(50): 48938 - 48943. [Abstract] [Full Text] [PDF]

				H. Yagyu, E. P. Lutz, Y. Kako, S. Marks, Y. Hu, S. Y. Choi, A. Bensadoun, and I. J. Goldberg Very Low Density Lipoprotein (VLDL) Receptor-deficient Mice Have Reduced Lipoprotein Lipase Activity. POSSIBLE CAUSES OF HYPERTRIGLYCERIDEMIA AND REDUCED BODY MASS WITH VLDL RECEPTOR DEFICIENCY J. Biol. Chem., March 15, 2002; 277(12): 10037 - 10043. [Abstract] [Full Text] [PDF]

				J. W. Furbee Jr., J. K. Sawyer, and J. S. Parks Lecithin:Cholesterol Acyltransferase Deficiency Increases Atherosclerosis in the Low Density Lipoprotein Receptor and Apolipoprotein E Knockout Mice J. Biol. Chem., January 25, 2002; 277(5): 3511 - 3519. [Abstract] [Full Text] [PDF]

				J. M. Martin-Campos, J. Julve, J. C. Escola, J. Ordonez-Llanos, J. Gomez, J. Binimelis, F. Gonzalez-Sastre, and F. Blanco-Vaca ApoA-IMALLORCA impairs LCAT activation and induces dominant familial hypoalphalipoproteinemia J. Lipid Res., January 1, 2002; 43(1): 115 - 123. [Abstract] [Full Text] [PDF]

				P. Siri, N. Candela, Y.-L. Zhang, C. Ko, S. Eusufzai, H. N. Ginsberg, and L.-S. Huang Post-transcriptional Stimulation of the Assembly and Secretion of Triglyceride-rich Apolipoprotein B Lipoproteins in a Mouse with Selective Deficiency of Brown Adipose Tissue, Obesity, and Insulin Resistance J. Biol. Chem., November 30, 2001; 276(49): 46064 - 46072. [Abstract] [Full Text] [PDF]

				P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II Circulation, November 13, 2001; 104(20): 2498 - 2502. [Full Text] [PDF]

				P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I Circulation, November 6, 2001; 104(19): 2376 - 2383. [Full Text] [PDF]

				J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance J. Lipid Res., February 1, 2001; 42(2): 241 - 248. [Abstract] [Full Text]

				Z. Li, Y. Kako, L. Pang, M. W. Freeman, J. M. Glick, X. Wang, and I. J. Goldberg Effects of overexpression of the amino-terminal fragment of apolipoprotein B on apolipoprotein B and lipoprotein production J. Lipid Res., December 1, 2000; 41(12): 1912 - 1920. [Abstract] [Full Text]

				T. A. Christiansen-Weber, J. R. Voland, Y. Wu, K. Ngo, B. L. Roland, S. Nguyen, P. A. Peterson, and W.-P. Fung-Leung Functional Loss of ABCA1 in Mice Causes Severe Placental Malformation, Aberrant Lipid Distribution, and Kidney Glomerulonephritis As Well As High-Density Lipoprotein Cholesterol Deficiency Am. J. Pathol., September 1, 2000; 157(3): 1017 - 1029. [Abstract] [Full Text] [PDF]

				J. C. Escolà-Gil, J. Julve, A. Marzal-Casacuberta, J. Ordóñez-Llanos, F. González-Sastre, and F. Blanco-Vaca Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia J. Lipid Res., August 1, 2000; 41(8): 1328 - 1338. [Abstract] [Full Text]

				M. G. Sorci-Thomas, M. Thomas, L. Curtiss, and M. Landrum Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Delta 6 and Wild-type ApoA-I in Transgenic Mice J. Biol. Chem., April 14, 2000; 275(16): 12156 - 12163. [Abstract] [Full Text] [PDF]

				K. F. Kozarsky, M. H. Donahee, J. M. Glick, M. Krieger, and D. J. Rader Gene Transfer and Hepatic Overexpression of the HDL Receptor SR-BI Reduces Atherosclerosis in the Cholesterol-Fed LDL Receptor-Deficient Mouse Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 721 - 727. [Abstract] [Full Text] [PDF]

				Y. Kako, L.-S. Huang, J. Yang, T. Katopodis, R. Ramakrishnan, and I. J. Goldberg Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice: effects on lipoproteins and atherosclerosis J. Lipid Res., December 1, 1999; 40(12): 2185 - 2194. [Abstract] [Full Text] [PDF]

				S. H. Zuckerman, G. F. Evans, J. A. Schelm, P. I. Eacho, and G. Sandusky Estrogen-Mediated Increases in LDL Cholesterol and Foam Cell–Containing Lesions in Human ApoB100CETP Transgenic Mice Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1476 - 1483. [Abstract] [Full Text] [PDF]

				W. A. Boisvert, A. S. Black, and L. K. Curtiss ApoA1 Reduces Free Cholesterol Accumulation in Atherosclerotic Lesions of ApoE–Deficient Mice Transplanted With ApoE–Expressing Macrophages Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 525 - 530. [Abstract] [Full Text] [PDF]

				H.-h. Li, D. S. Lyles, M. J. Thomas, W. Pan, and M. G. Sorci-Thomas Structural Determination of Lipid-bound ApoA-I Using Fluorescence Resonance Energy Transfer J. Biol. Chem., November 17, 2000; 275(47): 37048 - 37054. [Abstract] [Full Text] [PDF]